Drug Discount Plan Requires Fix by Congress, Program Oversight

A drug discount plan desperately needs a legislative fix to protect patients and enhance the government’s program oversight, 340B program advocates told senators recently.

Advocates and program members are asking Congress to pass stricter guidelines on who can qualify as a 340B-covered entity eligible for discounted outpatient drugs. They also recommended policies to ensure transparency and oversight of the program administered by the Health Resources and Services Administration.

The input comes after a bipartisan group of senators requested suggestions on the 340B drug pricing program that would help strengthen the program’s operations, savings, and spending. Among those looking at the ...